Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · IEX Real-Time Price · USD
10.25
-0.56 (-5.18%)
At close: Jul 2, 2024, 4:00 PM
10.80
+0.55 (5.37%)
After-hours: Jul 2, 2024, 5:53 PM EDT
Phathom Pharmaceuticals Market Cap
Phathom Pharmaceuticals has a market cap or net worth of $599.99 million as of July 2, 2024. Its market cap has increased by 13.50% in one year.
Market Cap
599.99M
Enterprise Value
727.46M
1-Year Change
13.50%
Ranking
Category
Stock Price
$10.25
Market Cap Chart
Since October 25, 2019, Phathom Pharmaceuticals's market cap has decreased from $636.70M to $599.99M, a decrease of -5.77%. That is a compound annual growth rate of -1.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 600.00M | 14.79% |
| Dec 29, 2023 | 522.70M | 11.93% |
| Dec 30, 2022 | 467.00M | -24.42% |
| Dec 31, 2021 | 617.90M | -35.78% |
| Dec 31, 2020 | 962.20M | 25.98% |
| Dec 31, 2019 | 763.80M | 19.96% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Wave Life Sciences | 611.15M |
| Clover Health Investments | 610.62M |
| Lexicon Pharmaceuticals | 607.31M |
| GH Research | 606.65M |
| Olema Pharmaceuticals | 605.20M |
| Varex Imaging | 602.46M |
| Zymeworks | 601.70M |
| Castle Biosciences | 601.01M |